Fullerene therapy for asthma
Short Summary
Fullerene compounds are a new chemotype to treat allergic and inflammatory asthma
Abstract
Fullerenes for the treatment of asthma is through a previously undescribed mechanism involving the upregulation of  antiinflammatory EETs. Evidence presented suggests that specific fullerene compound has the potential to become novel therapeutics for the treatment of asthma and pave the way to new research efforts focusing on the role of EETs in asthma.
Link